Tvax pulls IPO

Cancer company Tvax Biomedical Inc. (Lenexa, Kan.) withdrew its planned IPO, citing market conditions. The company had planned to sell 2 million shares at $9-$11 per share. A $10 price would have raised $20 million and valued the company at $78.5 million. Tvax filed to raise up to $40 million last November. ...